Elliott Levy

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Elliott Levy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elliott Levy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. Director Stock Option (right to buy) 37,500 06 Jun 2025 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 20 Jun 2024 Direct

Insider Reports Filed by Elliott Levy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EDIT Editas Medicine, Inc. 06 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:18
OMGAQ Omega Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:20
EDIT Editas Medicine, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:27
OMGAQ Omega Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:05
EDIT Editas Medicine, Inc. 11 Apr 2023 1 $0 4 Director 13 Apr 2023, 16:53
EDIT Editas Medicine, Inc. 11 Apr 2023 0 $0 3 Director 13 Apr 2023, 16:52
OMGAQ Omega Therapeutics, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:10
OMGAQ Omega Therapeutics, Inc. 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 21:04